Erica Stone

Dr. Stone is an award-winning immunologist with expertise in T cell immunology, immuno-oncology, and human immunology. At GigaGen as Vice President of Oncology she leads immuno-oncology research and discovery of antibody therapies with best-in-class potential. Previously Dr. Stone was Assistant Professor at The Wistar Institute Cancer Center where her independent laboratory focused on understanding the multiple mechanisms of action of first-generation immune checkpoint inhibitorswith the goal of identifying strategies to overcome resistance. She was awarded several grants for her research including the Melanoma Research Alliance’s Bristol-Myers Squibb-MRA Young Investigator Award and funding from the NIH. She also held the position Wistar Institute Assistant Professor of Pathology and Laboratory Medicine at the Perlman School of Medicine at the University of Pennsylvania where she was a member of the Institute for Immunology, the Immunology Graduate Group Executive Committee, and the Gene Therapy and Vaccines Program. Dr. Stone is an active member of the American Association of Immunologists (AAI), where she serves as Chair of the AAI-Clinical Immunology Committee. Previously Dr. Stone served as an AAI’s Tumor

Immunology Abstract Programming Co-Chair, was an AAI Public Policy Fellow, and was the 2017 recipient of AAI’s Chambers-Thermo Fisher Scientific Memorial Award. Dr. Stone has published numerous manuscripts in journals including Immunity, Nature Reviews Immunology, Science, Cancer Immunology Research, ELife, and PNAS, mentored students and postdoctoral fellows, and served as a reviewer for study sections and journals.

Dr. Stone holds a B.S. in Biology summa cum laude from the University of New Hampshire and a Ph.D. in Biological Sciences from UC-San Diego where she also completed a postdoctoral fellowship.